Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.
about
Biogenesis and function of Porphyromonas gingivalis outer membrane vesiclesInsights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsBiohybrid polymer-antimicrobial peptide medium against Enterococcus faecalisDefensins as anti-inflammatory compounds and mucosal adjuvantsOral antimicrobial peptides and biological control of cariesThe expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitisAssociation of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytesDifferential activity of innate defense antimicrobial peptides against Nocardia species.Perspectives for clinical use of engineered human host defense antimicrobial peptidesPeptide-based Antifungal Therapies against Emerging Infections.Salivary antimicrobial peptide expression and dental caries experience in childrenDichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins.A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicansInnate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae.Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.A lactotransferrin single nucleotide polymorphism demonstrates biological activity that can reduce susceptibility to cariesAntimicrobial peptides in the oral environment: expression and function in health and disease.Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.A site-specific recombinase-based method to produce antibiotic selectable marker free transgenic cattleInteraction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3.Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-WEpigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria.Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed cultureAntimicrobial peptides and proteins of the horse--insights into a well-armed organism.Synergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblastsHuman beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruptionMechanisms of decreased susceptibility to beta-defensins by Treponema denticola.Epithelial cells and innate antifungal defense.Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1αAntimicrobial peptides and surfactant proteins in ruminant respiratory tract diseaseTissue-specific human beta-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture systemResistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independentHuman beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity.The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.Innate immune response to oral bacteria and the immune evasive characteristics of periodontal pathogens.Candida glabrata: an emerging oral opportunistic pathogen.Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine
P2860
Q26783553-B335D34E-4A1F-4F9D-B1D2-4AF346A5CDA5Q26991996-F097F35A-C909-4C41-8B45-3ED9FC999625Q28543531-8F2C30D3-BECE-4696-A236-F932504CAFB6Q28748926-A092EFE9-A7F3-4833-B63C-048AD2056275Q33255353-6B7D53C6-61A6-4713-B67C-5F1F1ECD1C94Q33467053-1BC16669-F76E-4D82-B433-D4E9CEF1C462Q33497628-82534F64-AB43-4712-99B6-9F9DDCC8367CQ33533652-F7D76FCA-C5BC-4D63-8814-FEEBB76CF630Q33700825-FF3BC41A-1407-4DB0-98DB-0EFF861C1C0FQ33862289-6C0918FE-3DD3-4C60-8BD4-0F7688BBC894Q33935236-598631AB-0C01-4B77-8D61-ED58D3DC44ABQ34076596-31BD540E-9673-4696-BDDF-16D215450134Q34102682-DC53E09B-F3B4-4345-9E1C-24A5E8637436Q34253592-257B40CD-EF1D-48F5-898F-03313A96B8F5Q34301662-611B6948-443B-4B50-B7CB-590FEA63A746Q34509765-65DCD5F8-AAFB-49F9-AE7C-EFF6805BEEB2Q34608160-C8741E16-878B-4B70-804B-1D399876C57BQ34684398-0F7FAEAB-4BAC-4752-B56E-18C3743B73DAQ34684434-02B097C5-C64E-4D8F-A343-33DBAD57BBE3Q34712517-CDAF9C94-6E32-4941-98DA-CC943FF863D4Q34739171-31DBACB4-BC1B-43D3-960D-9113E874E924Q34971908-A15A2AB3-6683-450D-A0EF-7C5C01774282Q35032803-3FEC4F8D-4DD1-4926-BC96-4601C3829570Q35056340-5456539D-5776-4F89-97EB-E843DA574DD2Q35203439-87E14259-276C-491B-A645-8974974E31D3Q35232039-C4E8CC34-70DE-48FE-92BA-A562B6FD67D9Q35238104-5ABD73D2-2D8A-4D9D-BF56-5AB2EC514DE2Q35635804-C7BA3398-6E0E-48CB-A01E-DC67CB6220F9Q35784013-C2985692-742F-4BC2-8293-7EADB8EBD0AFQ35866679-E833D8DF-592F-45E0-82A9-9A549F51776BQ36142167-FB6A6927-E8DD-4FD6-BD23-A491D0B7E700Q36248322-8E5B8647-68ED-4143-B5F7-9ADD7886A673Q36390494-72DE4EE2-EC14-4ADA-921C-E98DA8CF0722Q36425009-48A0A409-7E8F-4E3D-90CC-72B15A76BCFDQ36451101-4A90C6B3-45F3-4C28-8D12-76F4603E26D0Q36587156-0B131502-BBF4-49C9-BA1D-7B2F38665688Q36655079-46152E5E-6F98-4677-A50D-2CCCCA57000DQ36681720-B0330954-76F0-492C-9074-A8BACDEC03E1Q36741765-2EEF8042-41D1-433E-B6A9-D2CE263B7E20Q37219481-A7B6BA75-528F-47C7-A177-352A16EB513E
P2860
Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Human beta-defensins 2 and 3 d ...... y against oral microorganisms.
@en
type
label
Human beta-defensins 2 and 3 d ...... y against oral microorganisms.
@en
prefLabel
Human beta-defensins 2 and 3 d ...... y against oral microorganisms.
@en
P2093
P2860
P1476
Human beta-defensins 2 and 3 d ...... y against oral microorganisms.
@en
P2093
Connie Maze
Janet M Guthmiller
Sophie Joly
P2860
P304
P356
10.1128/JCM.42.3.1024-1029.2004
P407
P577
2004-03-01T00:00:00Z